Sun Pharma gets approval for Winlevi in Australia
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
acne vulgaris
Sun Pharma Canada launches WINLEVI for acne
WINLEVI is the first and only topical androgen receptor inhibitor